Patterns of Basal Signaling Heterogeneity Can Distinguish Cellular Populations with Different Drug Sensitivities

Overview

Journal Mol Syst Biol

Specialty Molecular Biology

Date 2010 May 13

PMID 20461076

Citations 74

Authors

Dinesh Kumar Singh

Chin-Jen Ku

Chonlarat Wichaidit

Robert J Steininger 3rd

Lani F Wu

Steven J Altschuler

Affiliations

Soon will be listed here.

Abstract

Phenotypic heterogeneity has been widely observed in cellular populations. However, the extent to which heterogeneity contains biologically or clinically important information is not well understood. Here, we investigated whether patterns of basal signaling heterogeneity, in untreated cancer cell populations, could distinguish cellular populations with different drug sensitivities. We modeled cellular heterogeneity as a mixture of stereotyped signaling states, identified based on colocalization patterns of activated signaling molecules from microscopy images. We found that patterns of heterogeneity could be used to separate the most sensitive and resistant populations to paclitaxel within a set of H460 lung cancer clones and within the NCI-60 panel of cancer cell lines, but not for a set of less heterogeneous, immortalized noncancer human bronchial epithelial cell (HBEC) clones. Our results suggest that patterns of signaling heterogeneity, characterized as ensembles of a small number of distinct phenotypic states, can reveal functional differences among cellular populations.

Citing Articles

Targeting therapy-persistent residual disease.

Sun X, Wu L, Altschuler S, Hata A Nat Cancer. 2024; 5(9):1298-1304.

PMID: 39289594 DOI: 10.1038/s43018-024-00819-9.

Systematic data analysis pipeline for quantitative morphological cell phenotyping.

Ghanegolmohammadi F, Eslami M, Ohya Y Comput Struct Biotechnol J. 2024; 23:2949-2962.

PMID: 39104709 PMC: 11298594. DOI: 10.1016/j.csbj.2024.07.012.

Multi-omics analysis defines 5-fluorouracil drug resistance in 3D HeLa carcinoma cell model.

Wang L, Wang X, Wang T, Zhuang Y, Wang G Bioresour Bioprocess. 2024; 8(1):135.

PMID: 38650282 PMC: 10991626. DOI: 10.1186/s40643-021-00486-z.

Extended methods for spatial cell classification with DBSCAN-CellX.

Kuchenhoff L, Lukas P, Metz-Zumaran C, Rothhaar P, Ruggieri A, Lohmann V Sci Rep. 2023; 13(1):18868.

PMID: 37914751 PMC: 10620226. DOI: 10.1038/s41598-023-45190-4.

Embryonic stem cell ERK, AKT, plus STAT3 response dynamics combinatorics are heterogeneous but NANOG state independent.

Reimann A, Kull T, Wang W, Dettinger P, Loeffler D, Schroeder T Stem Cell Reports. 2023; 18(6):1295-1307.

PMID: 37207650 PMC: 10277824. DOI: 10.1016/j.stemcr.2023.04.008.

References

Campbell L, Polyak K . Breast tumor heterogeneity: cancer stem cells or clonal evolution?. Cell Cycle. 2007; 6(19):2332-8. DOI: 10.4161/cc.6.19.4914. View

Elsasser W . Outline of a theory of cellular heterogeneity. Proc Natl Acad Sci U S A. 1984; 81(16):5126-9. PMC: 391650. DOI: 10.1073/pnas.81.16.5126. View

Liegl B, Kepten I, Le C, Zhu M, Demetri G, Heinrich M . Heterogeneity of kinase inhibitor resistance mechanisms in GIST. J Pathol. 2008; 216(1):64-74. PMC: 2693040. DOI: 10.1002/path.2382. View

Schlabach M, Luo J, Solimini N, Hu G, Xu Q, Li M . Cancer proliferation gene discovery through functional genomics. Science. 2008; 319(5863):620-4. PMC: 2981870. DOI: 10.1126/science.1149200. View

Rubin H . The significance of biological heterogeneity. Cancer Metastasis Rev. 1990; 9(1):1-20. DOI: 10.1007/BF00047585. View

Kozaki K, Miyaishi O, Tsukamoto T, Tatematsu Y, Hida T, Takahashi T . Establishment and characterization of a human lung cancer cell line NCI-H460-LNM35 with consistent lymphogenous metastasis via both subcutaneous and orthotopic propagation. Cancer Res. 2000; 60(9):2535-40. View

Shankavaram U, Varma S, Kane D, Sunshine M, Chary K, Reinhold W . CellMiner: a relational database and query tool for the NCI-60 cancer cell lines. BMC Genomics. 2009; 10:277. PMC: 2709662. DOI: 10.1186/1471-2164-10-277. View

Engelman J, Zejnullahu K, Mitsudomi T, Song Y, Hyland C, Park J . MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science. 2007; 316(5827):1039-43. DOI: 10.1126/science.1141478. View

Boland M, Murphy R . A neural network classifier capable of recognizing the patterns of all major subcellular structures in fluorescence microscope images of HeLa cells. Bioinformatics. 2001; 17(12):1213-23. DOI: 10.1093/bioinformatics/17.12.1213. View

10.

Vaughan M, Ramirez R, Wright W, Minna J, Shay J . A three-dimensional model of differentiation of immortalized human bronchial epithelial cells. Differentiation. 2006; 74(4):141-8. DOI: 10.1111/j.1432-0436.2006.00069.x. View

11.

Barre B, Vigneron A, Perkins N, Roninson I, Gamelin E, Coqueret O . The STAT3 oncogene as a predictive marker of drug resistance. Trends Mol Med. 2006; 13(1):4-11. DOI: 10.1016/j.molmed.2006.11.001. View

12.

Loo L, Lin H, Steininger 3rd R, Wang Y, Wu L, Altschuler S . An approach for extensibly profiling the molecular states of cellular subpopulations. Nat Methods. 2009; 6(10):759-65. PMC: 2818727. DOI: 10.1038/nmeth.1375. View

13.

Anderson A, Weaver A, Cummings P, Quaranta V . Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell. 2006; 127(5):905-15. DOI: 10.1016/j.cell.2006.09.042. View

14.

Cohen A, Geva-Zatorsky N, Eden E, Frenkel-Morgenstern M, Issaeva I, Sigal A . Dynamic proteomics of individual cancer cells in response to a drug. Science. 2008; 322(5907):1511-6. DOI: 10.1126/science.1160165. View

15.

Heppner G . Tumor heterogeneity. Cancer Res. 1984; 44(6):2259-65. View

16.

Balaban N, Merrin J, Chait R, Kowalik L, Leibler S . Bacterial persistence as a phenotypic switch. Science. 2004; 305(5690):1622-5. DOI: 10.1126/science.1099390. View

17.

Bremnes R, Veve R, Hirsch F, Franklin W . The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. Lung Cancer. 2002; 36(2):115-24. DOI: 10.1016/s0169-5002(01)00471-8. View

18.

Nagrath S, Sequist L, Maheswaran S, Bell D, Irimia D, Ulkus L . Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature. 2007; 450(7173):1235-9. PMC: 3090667. DOI: 10.1038/nature06385. View

19.

J van t Veer L, Dai H, van de Vijver M, He Y, Hart A, Mao M . Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002; 415(6871):530-6. DOI: 10.1038/415530a. View

20.

Wilson A, Laurenti E, Oser G, van der Wath R, Blanco-Bose W, Jaworski M . Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell. 2008; 135(6):1118-29. DOI: 10.1016/j.cell.2008.10.048. View